Quantifying differences in feature importance rankings of #machinelearning #classification could enhance #interpretability and #explainability: we show how through the rank-biased overlap similarity measure. Take a look at my novel work!
Ever wondered how to quantitatively compare feature importance produced by Machine Learning algorithms?
In this new work presented at the Brain Informatics 2022, we introduce the Rank-Biased Overlap (RBO) as similarity measure for comparing rankings of features ordered by their importance. We used the automatic classification of Parkinson’s disease as case study.
The wide application of artificial intelligence (AI) and machine learning (ML) on neuroscience data represents an unprecedented way for understanding neurological diseases. The AI and ML could, indeed, deal with multi-modal, multi-dimensional, and multi-source data, which can help to extract new knowledge about the pathological mechanisms that affect the human brain and, more generally, the nervous system. This Special Issue of the Journal of Personalized Medicine is devoted to collect original scientific articles that explore neurological diseases through the use of AI and ML approaches. In particular, we accept works that apply supervised and unsupervised learning, reinforcement learning, deep learning, and the more recent explainable and interpretable ML methodologies. Moreover, we seek to collect studies using and exploring different source of data, such as neuroimaging (structural MRI, functional MRI and Nirs), neurophysiology (TMS, EMG, EEG, MEG), biorobotics, and biomechanics (inertial, wearable, IoT sensors) applied to neurodegenerative diseases.
Contributions such as systematic reviews or meta-analyses on the above-mentioned topics are also welcome.
Dr. Alessia Sarica Dr. Vera Gramigna Dr. Maria Giovanna Bianco Guest Editors
In case you missed the live, here the recording of the BI2021 Special Session on EXPLAINABLE ARTIFICIAL INTELLIGENCE FOR UNVEILING THE BRAIN: FROM THE BLACK-BOX TO THE GLASS-BOX (XAIB) 18th September 2021, 14:00-16:00 UK time (GMT+1), with Dr. Rich Caruana, Dr. Michele Ferrante and Dr. Dimitris Pinotsis: